Skip to main content
Joel Palefsky, MD, Infectious Disease, San Francisco, CA, UCSF Medical Center

JoelM.PalefskyMD

Infectious Disease • San Francisco, CA

Professor, Medicine, UCSF School of Medicine

Join to view full profile

Dr. Palefsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Palefsky's full profile

Already have an account?

Education & Training

  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1985 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Initial Development and Content Validation of a Health-Related Symptom Index for Persons Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions  
    Timothy J Wilkin, Joel M Palefsky, Value in Health

Lectures

  • Cancer Prevention Through Human Papillomavirus Vaccination 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
  • High Resolution Anoscopy (HRA) 
    American Society for Colposcopy and Cervical Pathology, Providence, Rhode Island - 4/27/2012

Other

Authored Content

  • Initial Development and Content Validation of a Health-Related Symptom Index for Persons Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial LesionsAugust 2018

Press Mentions

  • Winship Contributes to Anal Cancer/HSIL Outcomes Research (ANCHOR) Study
    Winship Contributes to Anal Cancer/HSIL Outcomes Research (ANCHOR) StudyJuly 13th, 2022
  • Risk of Anal Cancer Significantly Lower with Treatment for Anal High-Grade Squamous Intraepithelial Lesions
    Risk of Anal Cancer Significantly Lower with Treatment for Anal High-Grade Squamous Intraepithelial LesionsJune 22nd, 2022
  • Screening and Early Treatment Reduces Anal Cancer in People with HIV
    Screening and Early Treatment Reduces Anal Cancer in People with HIVJune 17th, 2022
  • Join now to see all

Grant Support

  • Incidence Of HIV Among Indian Men WHO Have Sex With MenNational Cancer Institute2011
  • Hpv-Related Neoplasia Among Hiv-Seropositive Indian Men WHO Have Sex With MenNational Cancer Institute2011
  • E6 Oncoprotein Based Rapid Test For Anal NeoplasiaNational Cancer Institute2010–2011
  • Determinants Of Participation In An Anal Cancer Prevention TrialNational Cancer Institute2009–2010
  • Oral S100A9 (CALPROTECTIN) In HIV InfectionNational Institute Of Dental &Craniofacial Research2007
  • UCSF Predoctoral Clinical Research Training Program (RMI)National Center For Research Resources2006
  • Anal HPV Infection And Asil In HIV+ And HIV- WomenNational Cancer Institute2001–2006
  • Oral S100A8 And S100A9 (CALPROTECTIN) In HIV InfectionNational Institute Of Dental &Craniofacial Research2005
  • Clinical And Laboratory CoreNational Institute Of Dental &Craniofacial Research2005
  • UCSF Predoctoral Clinical Research Training Program(Rmi)National Center For Research Resources2005
  • Prevalance And Risk Factors For Anal HPV Infection And Anal Squamous IntraepiNational Center For Research Resources2005
  • Anal HPV Infection And Asil In HIV+ And HIV- MenNational Center For Research Resources2005
  • SGN-00101 In High-Grade Anal Intraepithelial Neoplasia (AIN) In HIV+ IndividualsNational Center For Research Resources2004–2005
  • Infrared Coagulator For Squamous Intraepithelial Neoplasia Of Anus In HIV+National Center For Research Resources2004–2005
  • Anal HPV &Asil In HIV+ &Hiv- WomenNational Center For Research Resources2004–2005
  • HPV And Mrps In Oral Cancer PathogenesisNational Institute Of Dental &Craniofacial Research2001–2005
  • Natural HX Of Papilloma-Associated Mucosal Lesions, Normal And ImmunosuppressedNational Center For Research Resources2004
  • EBV And Responding Host Genes In HIV InfectionNational Institute Of Dental &Craniofacial Research2000–2004
  • Phase I/II Stage OPEN Label Noncomparative Study Of DFMO In HIV Infected MenNational Center For Research Resources1998–2002
  • Natural History Of Anal Neoplasia--Actg 216National Center For Research Resources1996–2002
  • Natural History Of Anal Neoplasia In HIV Infected MenNational Cancer Institute1994–2002
  • Epithelial/Stromal Interactions In Oral CancerNational Institute Of Dental &Craniofacial Research1996–2001
  • Molecular Pathogenesis 0f Hairy LeukoplakiaNational Institute Of Dental &Craniofacial Research1997–1999
  • Oral HPV Infection In Hiv-Positive Men And WomenNational Institute Of Dental &Craniofacial Research1994–1998
  • Anal Neoplasia In HIV Positive And HIV Negative WomenNational Cancer Institute1995–1997
  • Molecular Pathogenesis Of EBV Infection In Hairy LeukoplakiaNational Institute Of Dental &Craniofacial Research1995–1996
  • Oral HPV Infection In HIV Positive Men And WomenNational Institute Of Dental &Craniofacial Research1995
  • Natural History Of Anal Neoplasia In Hiv-Infected MenNational Cancer Institute1991–1995
  • Natural History Of Anal Neoplasia In HIV InfectionsNational Cancer Institute1994
  • Anal Neoplasia Chemoprevention In HIV Positive PersonsNational Cancer Institute1993–1994

Hospital Affiliations

Dr. Joel Palefsky, Dr. Joel Palefsky, MD, Dr. J Palefsky, Dr. Joel M. Palefsky